Key points
-
The ISSVA has recently updated its classification of vascular anomalies.
-
Vascular anomalies of the head and neck present unique diagnostic and therapeutic challenges.
-
Age and clinical history/presentation are important factors in diagnosis.
-
Vascular malformations and tumors may require multiple imaging modalities to fully characterize.
Background
Vascular Tumors | Presentation | Imaging | Important Considerations |
---|---|---|---|
Benign | |||
Infantile Hemangioma | Present at birth. | Prominent serpiginous feeding vessel. | Delineate depth of lesion. |
Most commonly diagnosed in the first year of life. Rapid growth followed by slower growth and involution phases. | Iso- to intermediate T1 signal. | If lesion crosses multiple layers consider Kaposiform hemangioendothelioma. | |
Hyperintense T2 signal. Increased T1 signal due to fibrofatty infiltration in the involuting phase and decreased contrast enhancement. | |||
Congenital Hemangioma | Usually present in the first year of life. | Intermediate T1 signal. High T2 signal. | Differentiated from infantile hemangiomas based on clinical course. |
Tufted Angioma | Develops within the first five years of life with red or violaceous plaques. | Imaging rarely performed. | |
Spindle Cell Hemangioma | Present as red or brown nodules. | Low T1 signal. High T2 signal lobulations. | Associated with Malfucci syndrome and Kaposiform hemangioendothelioma. |
May see associated lymphedema. | Often with phleboliths due to abnormal venous vasculature. | ||
Pyogenic Granuloma | Occur secondary to prior insult such as trauma or burns. | Isointense T1. Variable T2 signal. | |
Present with bleeding. | |||
Locally Aggressive/Borderline | |||
Kaposiform Hemangioendothelioma | Most common aggressive tumor. | Predominantly hyperintense T2 signal with aggressive features (ill defined margins, involvement of multiple tissue planes, stranding of the subcutaneous fat, and hemosiderin deposition due to prior hemorrhage). | |
Associated with thrombocytopenia and pain. | May involve adjacent bone. | ||
Hemangioendothelioma | Presents in adults as one or more slow growing nodules. | Usually evident on physical exam. | Distant metastasis rare. |
Papillary Intralymphatic Angioendothelioma | Primary involves the skin and subcutaneous tissues. | Isointense T1 signal. | Distant metastasis rare. |
Heterogeneously increased T2 signal. Variable enhancement. | |||
Often demonstrates local aggressive invasion. | |||
Malignant | |||
Angiosarcoma | Can occur at any age, mainly 7th and 8th decades of life. | Intermediate T1 signal intensity. High T2 heterogeneity. | Can metastasis to lung and bone via hematogenous spread. |
Most occur in the head and neck, particularly the scalp. | Avid, heterogeneous enhancement. Flow voids or high-flow serpentine loss of signal on T1 and T2 imaging in a soft tissue mass is characteristic. | ||
Can occur secondary to chronic lymphedema and radiation. | |||
Epithelioid Hemangioma | Often incidental. | Can present as well marginated lucent lesions when involving osseous structures on radiography. Osseous lesions demonstrate T1 signal hyperintense to muscle. Heterogeneous high T2. | Potential for metastasis depending on grade. |
Typically presents between 30-50 years of age. |
Vascular Malformations | Presentation | MR Imaging Characteristics | Additional helpful imaging characteristics |
---|---|---|---|
Capillary | Cutaneous lesions that often follow a dermal pattern. | Limited utility of imaging. | |
Can be used to exclude complicating components not obvious on physical exam. | |||
Additional imaging can be performed if a syndrome is suspected. | |||
Macrocystic Lymphatic | Present at birth or by two years of age. | Complex multiloculated cystic mass with fluid-fluid levels. Cysts typically larger than > 2 cm. Enhancement of the walls and septa on post contrast imaging. | US: large cystic structures without internal vascularity. |
Soft large translucent non tender mass. | |||
Microcystic Lymphatic | Present at birth or by two years of age. Grow slowly in proportion to growing child. | Transpatial T1 hypointense T2 hyperintense lesion with multiple small cysts typically less than 2cm. No enhancement. | |
May appear as several small, raised sacs on the skin. | |||
Venous | Most common type of vascular malformation. Slow flow vascular malformation presents as a non pulsatile compressible soft tissue prominence or discrete mass typically with blueish-purple hue. | T2 hyperintense serpiginous tubules that enhance on delayed phase. | CT: serpiginous lesions that enhance on post contrast imaging. More sensitive for phlebolith identification. |
Often tracking along muscle groups or nerves. These are responsive to changes in flow i.e. Valsalva. | T2 hypointense focal phleboliths. | ||
Venolymphatic | Present with characteristics of both lymphatic and venous malformation. | Multiloculated cystic mass with fluid-fluid levels. Some enhancement on delayed phase images. Phleboliths can be present. | CT: serpiginous lesions, some areas can enhance on post contrast imaging. More sensitive for phlebolith identification. |
Classically soft nontender mass can have a blueish-purple hue. | |||
AVM | Can present with CHF, embolism, pain, or bleeding depending on location. | Serpiginous tangle of vessels with enhancement on post contrast imaging and early enhancement of the draining veins. | DSA remains the gold standard. |
High flow vascular malformation can present with pulsating lesion or thrill on examination. May feel warm on palpation. | Serpiginous tangle or mass of vessels with enhancement on post contrast imaging and early enhancement of the enlarged draining veins. | ||
AVF | Symptoms depend on location and what vessels are involved. Can be asymptomatic and incidentally found. | Abnormal connection between an artery and vein, may present as abnormal dilation and fistulous tract on post contrast imaging. | DSA remains the gold standard and demonstrates direct communication of an artery with an abnormal early filling draining vein. |
Increased collateralization commonly seen. | Best seen on MRA which demonstrates abnormal early venous enhancement. |